Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

OBJECTIVE: The soluble urokinase plasminogen activator receptor (suPAR) has potential as a prognosis and severity biomarker in several inflammatory and infectious diseases. In a previous cross-sectional study, suPAR levels were shown to reflect damage accrual in cases of systemic lupus erythematosus...

Full description

Bibliographic Details
Main Authors: Enocsson, H, Wirestam, L, Dahle, C, Padyukov, L, Jönsen, A, Urowitz, M, Gladman, D, Romero-Diaz, J, Bae, S, Fortin, P, Sanchez-Guerrero, J, Clarke, A, Bernatsky, S, Gordon, C, Hanly, J, Wallace, D, Isenberg, D, Rahman, A, Merrill, J, Ginzler, E, Alarcón, G, Chatham, W, Petri, M, Khamashta, M, Aranow, C, Mackay, M, Dooley, M, Manzi, S, Ramsey-Goldman, R, Nived, O, Steinsson, K, Zoma, A, Ruiz-Irastorza, G, Lim, S, Kalunian, K, Inanc, M, Van Vollenhoven, R, Ramos-Casals, M, Kamen, D, Jacobsen, S, Peschken, C, Askanase, A, Stoll, T, Bruce, I, Wetterö, J, Sjöwall, C
Format: Journal article
Language:English
Published: Elsevier 2019

Similar Items